TF and COVID-19: Interestingly, in contrast to what was observed in the HSs, the presence of the neutralizing αTF antibody reduced Xa generation (−2.6 ± 2 pM/mL; p = 0.047) in 3 out of 10 acute COVID-19 patients, thus highlighting a functional TF activity.